General Information

Database Accession: DI3010002

Name: Alpha-chain of human fibrinogen bound to bovine epsilon-thrombin

PDB ID: 1bbr PDB

Experimental method: X-ray (2.30 Å)

Source organism: Homo sapiens / Bos taurus

Proof of disorder: Confirmed

Primary publication of the structure:

Martin PD, Robertson W, Turk D, Huber R, Bode W, Edwards BF
The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.

(1992) J. Biol. Chem. 267: 7911-20

PMID: 1560020 PubMed

Abstract:

The tetradecapeptide Ac-D-F-L-A-E-G-G-G-V-R-G-P-R-V-OMe, which mimics residues 7f-20f of the A alpha-chain of human fibrinogen, has been co-crystallized with bovine thrombin from ammonium sulfate solutions in space group P2(1) with unit cell dimensions of a = 83.0 A, b = 89.4 A, c = 99.3 A, and beta = 106.6 degrees. Three crystallographically independent complexes were located in the asymmetric unit by molecular replacement using the native bovine thrombin structure as a model. The standard crystallographic R-factor is 0.167 at 2.3-A resolution. Excellent electron density could be traced for the decapeptide, beginning with Asp-7f and ending with Arg-16f in the active site of thrombin; the remaining 4 residues, which have been cleaved from the tetradecapeptide at the Arg-16f/Gly-17f bond, are not seen. Residues 7f-11f at the NH2 terminus of the peptide form a single turn of alpha-helix that is connected by Gly-12f, which has a positive phi angle, to an extended chain containing residues 13f-16f. The major specific interactions between the peptide and thrombin are 1) a hydrophobic cage formed by residues Tyr-60A, Trp-60D, Leu-99, Ile-174, Trp-215, Leu-9f, Gly-13f, and Val-15f that surrounds Phe-8f; 2) a hydrogen bond linking Phe-8f NH to Lys-97 O;3) a salt link between Glu-11f and Arg-173; 4) two antiparallel beta-sheet hydrogen bonds between Gly-14f and Gly-216; and 5) the insertion of Arg-16f into the specificity pocket. Binding of the peptide is accompanied by a considerable shift in two of the loops near the active site relative to human D-phenyl-L-prolyl-L-arginyl chloromethyl ketone (PPACK)-thrombin.


Function and Biology Annotations from the GeneOntology database. Only terms that fit at least two of the interacting proteins are shown.

Molecular function:

receptor binding Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. GeneOntology

metal ion binding Interacting selectively and non-covalently with any metal ion. GeneOntology

Biological process:

platelet activation A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. GeneOntology

fibrinolysis A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin. GeneOntology

protein polymerization The process of creating protein polymers, compounds composed of a large number of component monomers; polymeric proteins may be made up of different or identical monomers. Polymerization occurs by the addition of extra monomers to an existing poly- or oligomeric protein. GeneOntology

positive regulation of protein phosphorylation Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. GeneOntology

proteolysis The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. GeneOntology

signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. GeneOntology

regulation of cell morphogenesis Any process that modulates the frequency, rate or extent of cell morphogenesis. Cell morphogenesis is the developmental process in which the shape of a cell is generated and organized. GeneOntology

positive regulation of intracellular signal transduction Any process that activates or increases the frequency, rate or extent of intracellular signal transduction. GeneOntology

positive regulation of multicellular organismal process Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs. GeneOntology

negative regulation of protein metabolic process Any process that stops, prevents, or reduces the frequency, rate or extent of chemical reactions and pathways involving a protein. GeneOntology

regulation of cell development Any process that modulates the rate, frequency or extent of the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. GeneOntology

humoral immune response An immune response mediated through a body fluid. GeneOntology

defense response to bacterium Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. GeneOntology

regulation of defense response Any process that modulates the frequency, rate or extent of a defense response. GeneOntology

regulation of protein localization Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location. GeneOntology

Cellular component:

external side of plasma membrane The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. GeneOntology

extracellular exosome A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. GeneOntology

blood microparticle A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. GeneOntology

Structure Summary Structural annotations of the participating protein chains.

Entry contents: 4 distinct polypeptide molecules

Chains: F, E, H, L

Notes: Chains F, J, K, G, M, N and I were removed as chains E, F, H and L highlight the biologically relevant interaction.

Chain F

Name: Fibrinogen alpha chain Disordered Confirmed

Source organism: Homo sapiens

Length: 11 residues

Sequence:Sequence according to PDB SEQRESGDFLAEGGGVR

UniProtKB AC: P02671 (positions: 25-35) UniProt Coverage: 1.3%

UniRef90 AC: UniRef90_P02671 (positions: 26-35) UniRef90

Chain E

Name: Prothrombin Ordered component

Source organism: Bos taurus

Length: 109 residues

Sequence:Sequence according to PDB SEQRESSVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLGS

UniProtKB AC: P00735 (positions: 517-625) UniProt Coverage: 17.4%

UniRef90 AC: UniRef90_P00735 (positions: 517-625) UniRef90

Chain H

Name: Prothrombin Ordered component

Source organism: Bos taurus

Length: 150 residues

Sequence:Sequence according to PDB SEQRESIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTT

UniProtKB AC: P00735 (positions: 367-516) UniProt Coverage: 24%

UniRef90 AC: UniRef90_P00735 (positions: 367-516) UniRef90

Chain L

Name: Prothrombin Ordered component

Source organism: Bos taurus

Length: 49 residues

Sequence:Sequence according to PDB SEQRESTSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR

UniProtKB AC: P00735 (positions: 318-366) UniProt Coverage: 7.8%

UniRef90 AC: UniRef90_P00735 (positions: 318-366) UniRef90

Evidence Evidence demonstrating that the participating proteins are unstructured prior to the interaction and their folding is coupled to binding.

Chain F: Disordered Confirmed

The interacting region of the protein has been shown to be highly flexible corresponding to missing coordinates in X-ray structure (PDB ID: 3h32).

Chain E: Ordered component

Thrombin consists of a large and a small subunit. Trypsin domain of the large subunit involved in the interaction is known to adopt a stable structure in isolation (see Pfam domain PF00089). A solved structure of a homologous thrombin domain is represented by PDB ID 3pmb.

Chain H: Ordered component

Thrombin consists of a large and a small subunit. Trypsin domain of the large subunit involved in the interaction is known to adopt a stable structure in isolation (see Pfam domain PF00089). A solved structure of a homologous thrombin domain is represented by PDB ID 3pmb.

Chain L: Ordered component

Thrombin consists of a large and a small subunit. Trypsin domain of the large subunit involved in the interaction is known to adopt a stable structure in isolation (see Pfam domain PF00089). A solved structure of a homologous thrombin domain is represented by PDB ID 3pmb.

Related Structure(s) Structures from the PDB that contain the same number of proteins, and the proteins from the two structures show a sufficient degree of pairwise similarity, i.e. they belong to the same UniRef90 cluster (the full proteins exhibit at least 90% sequence identity) and convey roughly the same region to their respective interactions (the two regions from the two proteins share a minimum of 70% overlap).

There is 1 related structure in the Protein Data Bank:


The molecule viewer shows our modified stucture.

The structure can be rotated by left click and hold anywhere on the structure. Representation options can be edited by right clicking on the structure window.

Download our modified structure (.pdb)

Download the original structure (.pdb)

Download this entry's XML file (.xml)